Form 4 for INGN Inogen Inc
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-016012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | F - Tax | $35.21 | -15.4K | 15.7K | -50% | -$542.1K |
| D | 2022-03-03 | 2022-03-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | A - Grant | $0.00 | +9,409 | 9,409 | New | $0 |
| D | 2022-03-03 | 2022-03-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | M - OptEx | $0.00 | +21.6K | 26.4K | +456% | $0 |
| D | 2022-03-03 | 2022-03-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | A - Grant | $0.00 | +39.1K | 39.1K | New | $0 |
| DM | 2022-03-03 | 2022-03-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | M - OptEx | $0.00 | -21.6K | 16.9K | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | F | D | 4,665 | $35.21 | 4,744 | D | — | — | (F2) The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2021 performance-based restricted stock award granted on March 1, 2021 and vested on March 1, 2022. |
| 2 | Common | Common Stock | 2022-03-01 | F | D | 10,730 | $35.21 | 15,655 | D | — | — | (F3) The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2022. |
| 3 | Common | Common Stock | 2022-03-01 | A | A | 9,409 | $0.00 | 9,409 | D | — | — | (F1) The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on March 1, 2021. |
| 4 | Common | Common Stock | 2022-03-01 | M | A | 21,641 | $0.00 | 26,385 | D | — | — | |
| 5 | Derivative | Restricted Stock Unit | 2022-03-01 | A | A | 39,051 | $0.00 | 39,051 | D | — · — to — | 39,051 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F7) Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. |
| 6 | Derivative | Restricted Stock Unit | 2022-03-01 | M | D | 4,705 | $0.00 | 14,114 | D | — · — to — | 4,705 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F5) Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. |
| 7 | Derivative | Restricted Stock Unit | 2022-03-01 | M | D | 16,936 | $0.00 | 16,936 | D | — · — to — | 16,936 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F6) Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. |